Quintiles Transnational Holdings News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

30.01.20	IQVIA’s Breakthrough Natural Language Processing Platform Receives 2019 Fierce Innovation Award (Businesswire)
29.01.20	IQVIA to Announce Fourth-Quarter and Full-Year 2019 Results and Issue 2020 Guidance on February 12, 2020 (Businesswire)
23.01.20	AP-HP, Europe’s Leading Clinical Research Center, and IQVIA Collaborate to Launch the Largest Clinical Investigation Site in Europe (Businesswire)
21.01.20	IQVIA Named to FORTUNE’s 2020 List of "World’s Most Admired Companies” (Businesswire)
19.12.19	AstraZeneca Selects IQVIA OCE to Help Further its Digital Focus (Businesswire)
30.10.19	IQVIA Reports Third-Quarter 2019 Results (Businesswire)
16.10.19	IQVIA to Announce Third-Quarter 2019 Results on October 30, 2019 (Businesswire)
02.10.19	IQVIA Launches Orchestrated Patient Engagement (Businesswire)
01.10.19	IQVIA Launches IQVIA Consumer Health to Meet the Growing Business Needs of the Retail Health Sector (Businesswire)
18.09.19	IQVIA Collaborates with Cancer Researchers to Advance Use of Real World Evidence (Businesswire)
17.09.19	IQVIA MedTech Launches Enhanced EQMS including EU MDR Support (Businesswire)
26.08.19	IQVIA Recommends Shareholders Reject "Mini-Tender” Offer by TRC Capital Investment Corporation (Businesswire)
21.08.19	IQVIA to Participate in Baird 2019 Global Healthcare Conference on September 4, 2019 (Businesswire)
15.08.19	IQVIA Launches Patient Portal to Transform the Clinical Trial Experience (Businesswire)
08.08.19	IQVIA Announces Repurchase of Common Stock (Businesswire)
08.08.19	IQVIA Announces Repurchase of Common Stock (Businesswire)
05.08.19	IQVIA Named Real World Evidence Market Leader (Businesswire)
01.08.19	IQVIA’s Cynthia Verst Honored on 2019 PharmaVOICE 100 List (Businesswire)
30.07.19	IQVIA Announces Pricing of Offering of Senior Notes (Businesswire)
29.07.19	IQVIA Announces Offering of Senior Notes (Businesswire)
24.07.19	IQVIA Reports Second-Quarter 2019 Results, Raises Full-Year Revenue and Adjusted Diluted EPS Guidance (Businesswire)
23.07.19	IQVIA Awarded Frost & Sullivan’s Life Sciences Product Leadership Award for Its Advanced Quality Management Technology Solution (Businesswire)
22.07.19	IQVIA Named to Forbes 2019 List of America’s Best Employers for Women (Businesswire)
09.07.19	IQVIA to Announce Second-Quarter 2019 Results on July 24, 2019 (Businesswire)
25.06.19	IQVIA Introduces Patient Centered Endpoints Solution with Transformative eCOA Technology Platform (Businesswire)
17.06.19	Chiesi Group Selects IQVIA’s OCE Technology Platform to Develop a Customer Centric Ecosystem across the Organization (Businesswire)
13.06.19	IQVIA’s OCE Technology Platform Selected by Ferring Pharmaceuticals (Businesswire)
04.06.19	IQVIA’s OCE Technology Platform Selected by Zambon to Establish a Global Multichannel Commercial Engagement Model for OTC Business (Businesswire)
30.05.19	IQVIA Real World Capabilities and Expertise Support Path to Label Expansion (Businesswire)
30.05.19	IQVIA™ Institute for Human Data Science Releases Global Oncology Trends 2019 Study: Record Number of Cancer Drugs Launched in 2018 across 17 Indications (Businesswire)
28.05.19	IQVIA Women Leaders Recognized for Their Outstanding Contributions to the Advancement of Healthcare (Businesswire)
23.05.19	IQVIA to Participate in William Blair Growth Stock Conference on June 5, 2019 (Businesswire)
14.05.19	IQVIA to Host Financial Analyst and Investor Conference on June 18, 2019 (Businesswire)
13.05.19	IQVIA Launches IQVIA MedTech Dedicated to Medical Device and Diagnostics Industry (Businesswire)
09.05.19	IQVIA™ Institute for Human Data Science Releases 2019 Medicines Report on U.S. Drug Consumption; U.S. Rx Opioid Volume Declined 17% in 2018 – Largest Single-Year Drop Ever Recorded (Businesswire)
07.05.19	IQVIA Announces Pricing of Offering of Senior Notes (Businesswire)
07.05.19	IQVIA Announces Offering of Senior Notes (Businesswire)
01.05.19	IQVIA Reports First-Quarter 2019 Results, Reaffirms Full-Year Guidance (Businesswire)
25.04.19	IQVIA’s OCE Technology Platform Selected by Salehiya Medical to Enhance Customer Experience in Saudi Arabia (Businesswire)
23.04.19	IQVIA Institute for Human Data Science Study: Record 59 New U.S. Drugs Launched in 2018, Success Rates Fall, R&D Trends Could Improve Productivity by 2023 (Businesswire)
17.04.19	IQVIA to Announce First-Quarter 2019 Results on May 1, 2019 (Businesswire)
09.04.19	IQVIA Releases Enhanced OCE Capability (Businesswire)
06.03.19	IQVIA Announces Pricing of Secondary Public Offering (Businesswire)
05.03.19	IQVIA Announces Launch of Secondary Public Offering and Repurchase of Common Stock (Businesswire)
05.03.19	IQVIA Launches E360 Genomics (Businesswire)
04.03.19	IQVIA’s FluSTAR Online Dynamic Platform Helps Consumers Track Local Rates of Flu, Allergy and Asthma (Businesswire)
28.02.19	IQVIA to Present at the Barclays Global Healthcare Conference on March 12, 2019 (Businesswire)
21.02.19	Carol J. Burt Joins IQVIA Board of Directors (Businesswire)
14.02.19	IQVIA Reports Fourth-Quarter and Full-Year 2018 Results, Issues First-Quarter and Full-Year 2019 Guidance (Businesswire)
11.02.19	IQVIA Introduces RIM Smart, the Industry’s First Fully Integrated, End-to-End Regulatory Information Management System (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Quintiles Transnational Holdings INC

Aktien Top/Flop

Meistgelesene Nachrichten